Fu-Dong Shi | Neuroimmunology | Best Researcher Award

Prof. Fu-Dong Shi | Neuroimmunology | Best Researcher Award

Dr. Fu-Dong Shi is a distinguished neurologist and Professor of Neurology at Beijing Tiantan Hospital and Tianjin Medical University General Hospital. With extensive training from institutions like Peking Union Hospital and the Karolinska Institute, he specializes in neuroinflammatory disorders, particularly multiple sclerosis, neuromyelitis optica, myasthenia gravis, and inflammatory neuropathy. Dr. Shi has published over 300 articles in leading journals and has been recognized with membership in the Academia Europaea. He is a prominent leader in clinical neuroimmunology, contributing to groundbreaking research, clinical trials, and the development of diagnostic and therapeutic interventions.

Prof. Fu-Dong Shi | Tianjin Medical University | China

🎓Education

  • Dr. Fu-Dong Shi completed his clinical and research training at Peking Union Hospital, the Karolinska Institute, The Scripps Research Institute, and the Barrow Neurological Institute, gaining extensive experience in neuroinflammatory disorders.

👨‍🏫Experience

  • Dr. Shi currently serves as a Professor of Neurology at both Beijing Tiantan Hospital and Tianjin Medical University General Hospital. He is also the Chief of the Neuroimmunology Section at the Chinese Neurological Association. With a long career in academia and clinical research, he has collaborated with several prominent researchers and institutions across the globe, including the Karolinska Institute, Oxford University, Charité – Universitätsmedizin Berlin, and leading pharmaceutical companies.

🏆Awards and Recognitions

  • Dr. Shi has been elected as a member of the Academia Europaea in 2024 for his distinguished contributions to the research and care of patients with neuroinflammatory disorders. His innovative research has earned recognition in numerous prestigious journals such as Nature Immunology, Immunity, and Nature Reviews Immunology.

💡Skills and Certifications

  • Dr. Shi is a renowned expert in the field of neuroimmunology, with specialized knowledge in the immune responses of the central nervous system. His skill set includes advanced research in multiple sclerosis, neuromyelitis optica spectrum disorders, myasthenia gravis, and inflammatory neuropathy. He has also been instrumental in developing diagnostic technologies and therapeutic interventions for these conditions.

🔬 Research Focus

  • Dr. Shi’s research primarily focuses on the clinical and basic studies of multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), myasthenia gravis (MG), and inflammatory neuropathy. His groundbreaking work has advanced the understanding of immune responses within the central nervous system, particularly in relation to brain ischemia, hemorrhage, and neuroimmune interactions. His research aims to drive innovative clinical trials testing immune interventions for neuroinflammatory disorders and exploring new diagnostic and therapeutic approaches for neuromyelitis optica and myasthenia gravis.

🌎Conclusion

  • Dr. Fu-Dong Shi’s groundbreaking research and leadership in neuroimmunology have earned him a reputation as one of the most influential researchers in the field. His work has provided valuable insights into immune system involvement in neurological diseases and led to the development of novel diagnostic and therapeutic approaches. Dr. Shi’s dedication to advancing scientific understanding and improving patient care makes him an outstanding candidate for the Best Researcher Award

📖Publications

  • Spatial structural abnormality maps associated with cognitive and physical performance in relapsing-remitting multiple sclerosis
    Authors: Z. Zhuo, N. Zhang, F. Ao, D. Tian, Y. Liu
    Journal: European Radiology, 2025

  • Multiplex proteomics identifies inflammation-related plasma biomarkers for aging and cardio-metabolic disorders
    Authors: S. Wu, Y. Li, X. Zhao, F. Shi, J. Chen
    Journal: Clinical Proteomics, 2024

  • Deep learning enables accurate brain tissue microstructure analysis based on clinically feasible diffusion magnetic resonance imaging
    Authors: Y. Li, Z. Zhuo, C. Liu, C. Ye, Y. Liu
    Journal: NeuroImage, 2024

  • Differential diagnosis of suspected multiple sclerosis: global health considerations
    Authors: J.D. Correale, A.J. Solomon, J.A. Cohen, B.I. Yamout, K. Fujihara
    Journal: [No source information available]

  • High Frequency of Autoantibodies in COVID-19 Patients with Central Nervous System Complications: a Multicenter Observational Study
    Authors: J. Lin, D. Zheng, D. Tian, F. Shi, H. Wang
    Journal: Molecular Neurobiology, 2024

Xiaoling Lv | Immune Response | Young Scientist Award

Assoc. Prof. Dr. Xiaoling Lv | Immune Response | Young Scientist Award

Lv Xiaoling is a professor at Shanxi Agricultural University specializing in veterinary pathology and molecular virology. With extensive experience in teaching and research, Lv has led multiple courses and participated in significant national research projects. The primary research focuses on the mechanisms of nerve injury caused by porcine hemagglutinating encephalomyelitis virus (PHEV) and host cell damage induced by Eimeria parasites in poultry. Contributions include multiple SCI publications, a national patent, and recognition through various research grants and awards.

Assoc. Prof. Dr. Xiaoling Lv | Shanxi Agricultural University | China

Profile

SCOPUS ID

🎓Education

  • Lv Xiaoling obtained a doctoral degree with a focus on veterinary pathology and virology. During the doctoral stage, the research primarily centered on the mechanism of nerve injury caused by porcine hemagglutinating encephalomyelitis virus (PHEV), leading to significant contributions in the field of veterinary medicine.

👨‍🏫Experience

  • As a professor at Shanxi Agricultural University, Lv Xiaoling leads multiple undergraduate courses, including Veterinary Pathology, Veterinary Pathological Anatomy, Veterinary Pathophysiology, and Veterinary Clinical Pathology. The professional journey includes active participation in several high-impact research projects, such as three general projects of the National Natural Science Foundation of China, a National Youth Science Foundation project, and a National Key Research and Development project.

🏆Awards and Recognitions

  • Lv Xiaoling has received various honors, including funding from the Applied Basic Research Program of Shanxi Province, the Shanxi Province Excellent Doctor Work Reward Fund, and the Science and Technology Innovation Fund of Shanxi Agricultural University. These recognitions highlight the contributions made in veterinary pathology and research on host cell damage mechanisms.

💡Skills and Certifications

  • Lv Xiaoling possesses expertise in veterinary pathology, molecular virology, and host-pathogen interactions. The research contributions include multiple publications in renowned journals such as Poultry Science, Parasitology Research, Veterinary Microbiology, and Frontiers in Microbiology. Additionally, there is a patent under process (CN202410568021.7), showcasing innovation in veterinary research.

🔬 Research Focus

  • The primary research areas include investigating the damage mechanisms caused by Eimeria parasites in chickens and understanding the molecular pathways of PHEV infection in nerve cells. The research has contributed to applied basic science, with projects focusing on host cell damage mechanisms, apoptosis pathways, and intracellular trafficking during viral infections.

🌎Conclusion

  • Lv Xiaoling’s work in veterinary pathology and host-pathogen interactions has significantly advanced understanding in the field. Through dedicated research and teaching, valuable insights have been gained into viral infections and parasitic damage mechanisms, contributing to disease prevention and control in animal health.

📖Publications

  • EtROP38 suppresses apoptosis of host cells infected with Eimeria tenella by inhibition of the p38MAPK pathway
    Authors: Buting Duan, Haoyu Zhang, Zi Hao Song, Xiaoling Lv, Mingxue Zheng, et al.
    Journal: Veterinary Parasitology, 2024